Global Tyrosine Kinase JAK Inhibitors Market Survey and Trend Research 2018
SUMMARY
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Tyrosine Kinase JAK Inhibitors Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 TYROSINE KINASE JAK INHIBITORS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Incyte (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Novartis (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Eli Lilly (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Sanofi (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Sanofi (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Galapagos (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 AbbVie (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Vertex (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Teva (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Astellas Pharma (Company Overview, Sales Data etc.)
4.12 Celgene (Company Overview, Sales Data etc.)
4.13 CTI BioPharma (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Tyrosine Kinase JAK Inhibitors Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 TYROSINE KINASE JAK INHIBITORS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
PART 4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Incyte (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Novartis (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Eli Lilly (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Sanofi (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Sanofi (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Galapagos (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 AbbVie (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Vertex (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Teva (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Astellas Pharma (Company Overview, Sales Data etc.)
4.12 Celgene (Company Overview, Sales Data etc.)
4.13 CTI BioPharma (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Type, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Incyte Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galapagos Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CTI BioPharma Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of CTI BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume 2012-2017, by Companies, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies in 2017, in Volume
Table Tyrosine Kinase JAK Inhibitors Demand 2012-2017, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand 2012-2017, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2018-2023, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2018-2023, by Application, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Region, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Region, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Type, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Incyte Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galapagos Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CTI BioPharma Overview List
Table Tyrosine Kinase JAK Inhibitors Business Operation of CTI BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume 2012-2017, by Companies, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies in 2017, in Volume
Table Tyrosine Kinase JAK Inhibitors Demand 2012-2017, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand 2012-2017, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2018-2023, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2018-2023, by Application, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2012-2017, by Region, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Tyrosine Kinase JAK Inhibitors Industry Chain Structure
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2012-2017, by Type, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2012-2017, by Type, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Tyrosine Kinase JAK Inhibitors Industry Chain Structure
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2012-2017, by Type, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2012-2017, by Type, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
